EMM Disclosure - Amendment
2003年7月4日 - 3:22AM
RNSを含む英国規制内ニュース (英語)
RNS Number:1615N
UBS AG (EMM)
03 July 2003
FORM 38.5 (SUMMARY)
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which
dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM UBS AG
Date of disclosure 03-Jul-2003
Contact Name Brenton Amedee
Telephone number 0207 568 4981
Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies:
POWDERJECT PHARMACEUTICALS
AMENDMENT TO SHARES BOUGHT AND SOLD IN POWDERJECT PHARMACEUTICALS
If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element(s) of previous
disclosure was incorrect:
In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the
nature of the dealings can be fully understood. For options this should include the number of securities under option,
the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or
received. For derivatives this should include, at least, the number of reference securities to which they relate (when
relevant), the maturity date (or if applicable the closing out date) and the reference price.For full details of
disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel
No:
020-7638 0129.
amendment
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in POWDERJECT PHARMACEUTICALS
Class of securities ORD GBP0.10
Date of disclosure 03-Jul-2003
Date of dealing 02-Jul-2003
Name of EMM UBS AG
Name of offeree / offeror with whom connected Chiron Corp
Total Number of securities bought 0
Highest price paid* 0 GBP
Lowest price paid* 0 GBP
Total Number of securities sold 0
Highest price received* 0 GBP
Lowest price received* 0 GBP
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMUUUPPMUPWGRW